Skip to main content
OMDAOmada Health, Inc.Hold6.3·$20.05+1.93%

Omada Health (OMDA) Q2 2026 earnings — TrendMatrix coverage

BEAT+219.8% vs estimateEPS $0.20 vs $0.06 estCurrent verdict Hold 6.3/10

Reported

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure

Event detail · Q2 2026

Key numbers

Reported EPS
$0.20
Estimate
$0.06
Surprise
+219.8%
Score today
6.3/10

Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.

Report record · Q2 2026

How the report landed

Omada Health (OMDA) beat the $0.06 estimate with diluted EPS of $0.20 — a large 219.8% upside surprise.

Current read · as of 2026-09-17

Where TrendMatrix's rating stands now

TrendMatrix currently rates OMDA Hold at 6.3/10; no pre/post engine snapshot brackets this report.

4 of the last 4 quarters beat the estimate; this quarter's +219.8% surprise compares with a +253.2% four-quarter average. Next scheduled report: 2026-11-05.

What supports the rating

  • Sector modifier (Healthcare): +0.5
  • Strong earnings beat streak (4/4)

What argues against it

  • Negative momentum
  • Value-trap signals (2/5): Margin compression (op margin 4.0%), Material insider selling (43 sells, 0.50% of cap)
  • Momentum score 3.0/10 — below 4.5 minimum

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current engine read

The levels TrendMatrix's engine tracks

Current price
$20.05
Price target
$24.72
Stop
$18.73
Upside to target
+23.3%
Reward-to-risk
2.0:1

Forward estimates sit below the trailing run-rate (35.4× forward vs 30.7× trailing) — consensus expects earnings to decline from here.

Risk check: RSI 30 — a level conventionally read as oversold.

Model outputs from TrendMatrix’s engine as of 2026-09-17 — shown for context, not personalized investment advice.

Healthcare context

OMDA at TrendMatrix's latest read

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry
Health Information Services
Market cap
$1.20B
P/E (fwd)
35.4
P/E (ttm)
30.7
52-week range
$10.28$26.91
Off 52-week high
25.5%
RSI (14)
30
Volume vs avg
0.79×
Score today
6.3/10

Earnings figures are sourced from TrendMatrix’s pipeline (EPS: existing earnings extraction; revenue: SEC XBRL company facts where available, yfinance-provisional otherwise). Not a buy/sell rating, a price target, or investment advice — see the current verdict on the stock’s main page for TrendMatrix’s live read.

Home Stocks OMDA Earnings Q2 2026 earnings